Tuesday, November 5, 2024
HomeTagsPeer-Reviewed Publication

Peer-Reviewed Publication

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof-of-Concept

Avenge Bio, Inc., a biotechnology company developing the LOCOcyte immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, ...

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof of Concept for LOCOcyte™ Platform Technology

Avenge Bio, Inc., ("Avenge" or the "Company") a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune effector molecules...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics